AI-crafted vaccine for a dog hints at a future where medicine is programmable
A dog named Rose reportedly received a personalized cancer vaccine designed with ChatGPT and Google’s DeepFold and manufactured by a university; while not cured, the cancer was greatly reduced and the dog’s quality of life improved. Tech investor Eric Jackson says this exemplifies “programmable medicine,” where AI-driven genomics and molecule design turn medicine into software, a shift that could boost biotech and AI-enabled stocks such as Moderna (MRNA) and platforms from Nvidia (NVDA), Alphabet (GOOGL), and Microsoft (MSFT), among others. The piece underscores the investment and regulatory implications of moving toward individualized therapies.